文献
J-GLOBAL ID:202202255360181609
整理番号:22A1177958
SARS-CoV-2誘導COVID-19における病因,進行,潜在的標的および標的治療戦略の進歩【JST・京大機械翻訳】
Advances in Pathogenesis, Progression, Potential Targets and Targeted Therapeutic Strategies in SARS-CoV-2-Induced COVID-19
著者 (8件):
Zhou Hong
(1Department of Pharmacy, Anhui Provincial Cancer Hospital, The First Affiliated Hospital of USTC, Division of Life Sciences and Medicine, University of Science and Technology of China, Hefei, China)
,
Ni Wei-Jian
(2Inflammation and Immune Mediated Diseases Laboratory of Anhui Province, The Key Laboratory of Anti-inflammatory of Immune Medicines, Ministry of Education, Anhui Institute of Innovative Drugs, School of Pharmacy, Anhui Medical University, Hefei, China)
,
Ni Wei-Jian
(3Anhui Provincial Hospital, The First Affiliated Hospital of USTC, Division of Life Sciences and Medicine, University of Science and Technology of China, Hefei, China)
,
Huang Wei
(4The Third People’s Hospital of Hefei, The Third Clinical College of Anhui Medical University, Hefei, China)
,
Wang Zhen
(5Anhui Provincial Children’s Hospital, Children’s Hospital of Fudan University-Anhui Campus, Hefei, China)
,
Cai Ming
(6Department of Pharmacy, The Second Affiliated Hospital of Anhui University of Chinese Medicine, Hefei, China)
,
Cai Ming
(7School of Pharmacy, Anhui University of Chinese Medicine, Hefei, China)
,
Sun Yan-Cai
(1Department of Pharmacy, Anhui Provincial Cancer Hospital, The First Affiliated Hospital of USTC, Division of Life Sciences and Medicine, University of Science and Technology of China, Hefei, China)
資料名:
Frontiers in Immunology (Web)
(Frontiers in Immunology (Web))
巻:
13
ページ:
834942
発行年:
2022年
JST資料番号:
U7074A
ISSN:
1664-3224
資料種別:
逐次刊行物 (A)
記事区分:
文献レビュー
発行国:
スイス (CHE)
言語:
英語 (EN)